Clinical Trials for Cellectar Biosciences

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cellectar Biosciences

Clinical Trials (3)

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

PHASE1Active, not recruiting

50 participants

Started: Oct 1, 2023 · Completed: Sep 30, 2026

1 condition2 sponsors8 locations

Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

PHASE1Active, not recruiting

30 participants

Started: Apr 30, 2019 · Completed: Dec 31, 2026

8 conditions1 sponsor8 locations

Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia

PHASE2Active, not recruiting

120 participants

Started: Jul 26, 2017 · Completed: Dec 22, 2026

9 conditions1 sponsor52 locations